Dr Agarwals Eye Hospital Ltd

Dr Agarwal's Eye Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Eye Hospital Ltd

₹ 4,750 -2.71%
22 Apr 10:50 a.m.
dragarwal.com BSE: 526783 NSE: DRAGARWQ
About

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Key Points

History[1]
Incorporated in 1994, is a leading eye care services chain with a predominant presence in Tamil Nadu. AEHL offers comprehensive eye care services through a network of 63 facilities, supported by a team of over 230 doctors. Company operates as a subsidiary of Dr. Agarwal’s Health Care Limited, which holds a 71.9% stake.

Website BSE NSE
  • Market Cap ₹ 2,296 Cr.
  • Current Price ₹ 4,750
  • High / Low ₹ 6,392 / 3,867
  • Stock P/E 32.9
  • Book Value ₹ 651
  • Dividend Yield 0.12 %
  • ROCE 17.5 %
  • ROE 29.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 32.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.2%

Cons

  • Stock is trading at 7.47 times its book value
  • Company might be capitalizing the interest cost
  • Promoters have pledged 29.3% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
64 69 79 84 76 81 100 102 95 100 117 118 116
48 48 56 61 55 56 69 72 69 68 80 78 82
Operating Profit 15 21 23 23 21 24 31 30 26 32 37 40 34
OPM % 24% 30% 29% 28% 27% 30% 31% 29% 27% 32% 32% 34% 30%
0 0 0 1 1 2 0 2 2 0 1 1 3
Interest 2 2 2 2 2 2 3 4 4 3 4 4 2
Depreciation 7 2 6 6 7 8 10 9 10 10 11 11 12
Profit before tax 7 18 16 17 13 17 19 19 14 19 23 26 23
Tax % 24% 25% 26% 24% 26% 26% 25% 26% 26% 14% 26% 25% 26%
5 14 12 13 9 13 14 14 10 16 17 19 17
EPS in Rs 10.77 29.11 24.55 26.79 20.09 27.21 30.02 30.11 22.13 34.02 36.72 39.98 35.76
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
113 118 137 149 153 170 176 140 201 268 319 397 451
102 103 119 126 129 140 129 109 143 192 227 277 308
Operating Profit 11 15 18 23 24 30 47 31 59 76 92 120 143
OPM % 9% 13% 13% 15% 16% 18% 27% 22% 29% 28% 29% 30% 32%
3 0 -5 1 2 2 3 1 1 2 5 5 4
Interest 4 4 5 4 3 4 9 7 7 8 8 15 13
Depreciation 6 6 9 9 10 11 21 19 20 20 27 39 44
Profit before tax 4 5 -0 11 13 17 20 6 32 49 62 71 91
Tax % 35% -6% -104% 33% 49% 32% 31% 125% 25% 25% 26% 23%
2 6 0 7 7 12 14 -1 24 37 46 55 70
EPS in Rs 5.17 12.13 0.09 15.62 14.43 25.36 29.11 -3.06 51.28 78.55 98.64 116.28 146.48
Dividend Payout % 23% 10% 940% 10% 8% 6% 0% 0% 6% 4% 3% 5%
Compounded Sales Growth
10 Years: 13%
5 Years: 18%
3 Years: 25%
TTM: 19%
Compounded Profit Growth
10 Years: 25%
5 Years: 32%
3 Years: 31%
TTM: 36%
Stock Price CAGR
10 Years: 40%
5 Years: 73%
3 Years: 61%
1 Year: 13%
Return on Equity
10 Years: 29%
5 Years: 30%
3 Years: 33%
Last Year: 30%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 5 5 5 5 5 5 5 5 5 5 5 5 5
Reserves 14 19 19 25 30 41 51 50 73 109 152 205 310
28 27 31 23 18 24 60 68 193 232 268 333 335
20 18 24 20 28 31 24 33 42 44 71 71 79
Total Liabilities 67 69 79 72 81 100 141 155 314 390 496 613 729
26 26 34 33 36 55 94 96 214 260 316 393 409
CWIP 0 0 1 1 3 0 0 0 26 62 97 128 157
Investments 0 0 0 0 0 0 0 0 0 0 0 13 85
41 43 44 38 42 45 47 60 73 67 83 80 79
Total Assets 67 69 79 72 81 100 141 155 314 390 496 613 729

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
12 14 17 20 19 25 39 34 57 70 90 94
-11 -10 -17 -8 -11 -25 -17 -11 -46 -71 -70 -133
-3 -5 -0 -12 -8 2 -20 -8 -4 0 -14 17
Net Cash Flow -2 -1 0 0 -0 2 2 15 7 -1 6 -22
Free Cash Flow 1 3 1 12 7 0 22 23 10 -1 19 -8
CFO/OP 113% 106% 113% 103% 98% 111% 96% 120% 112% 107% 112% 95%

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 19 19 24 16 17 19 14 23 16 14 15 13
Inventory Days 96 238 200 123 148 124 132 117 91 73 106 117
Days Payable 137 360 371 277 353 292 224 401 410 327 345 263
Cash Conversion Cycle -22 -103 -146 -138 -189 -149 -78 -260 -303 -240 -224 -133
Working Capital Days -52 -31 -39 -25 -39 -22 -34 -70 -58 -50 -63 -51
ROCE % 17% 19% 18% 29% 32% 34% 30% 11% 20% 19% 18% 18%

Insights

In beta
Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Facilities (AEHL Standalone)
Number

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees (AEHL)
Number
Number of Eye Care Facilities (Group)
Number
Total Patients Served (Group)
Millions
Number of Doctors (AEHL Standalone)
Number
Number of Doctors (Group)
Number
Total Patients Served (AEHL Standalone)
Number
Total Surgeries Performed (AEHL Standalone)
Number
Total Surgeries Performed (Group)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
71.89% 71.89% 71.89% 71.89% 71.90% 71.90% 71.90% 71.90% 71.90% 72.67% 72.67% 72.67%
0.00% 0.28% 0.63% 0.64% 0.65% 0.83% 0.84% 1.33% 1.49% 1.74% 1.82% 2.20%
0.00% 0.00% 0.00% 0.00% 0.00% 0.96% 1.04% 1.95% 2.31% 2.36% 2.36% 2.12%
28.10% 27.82% 27.47% 27.47% 27.46% 26.32% 26.22% 24.82% 24.29% 23.22% 23.15% 22.99%
No. of Shareholders 3,1693,4713,4233,5723,8084,51015,11541,70435,97630,52825,44924,036

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Aug 2025
    Transcript
    AI Summary
    PPT